Homestead Advisers Corp Abb Vie Inc. Transaction History

Homestead Advisers Corp

$3.96 Billion
Q4 2024

A detailed history of Homestead Advisers Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Homestead Advisers Corp holds 712,660 shares of ABBV stock, worth $150 Million. This represents 3.19% of its overall portfolio holdings.

Number of Shares

712,660

Previous 685,860 3.91%

Holding current value

$150 Million

Previous $135 Million 6.5%

% of portfolio

3.19%

Previous 3.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$164.99 - $203.87 $4.42 Million - $5.46 Million	26,800 Added 3.91%	712,660 $127 Million
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $81,920 - $99,665	-500 Reduced 0.07%	685,860 $135 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $1.87 Million - $2.19 Million	-12,100 Reduced 1.73%	686,360 $118 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $175,802 - $200,310	-1,100 Reduced 0.16%	698,460 $127 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $6.3 Million - $7.1 Million	-45,800 Reduced 6.14%	699,560 $108 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $16.2 Million - $18.7 Million	-121,127 Reduced 13.98%	745,360 $111 Million
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $10.6 Million - $13.1 Million	79,627 Added 10.12%	866,487 $117 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $2.46 Million - $2.83 Million	-17,000 Reduced 2.11%	786,860 $125 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $3.11 Million - $3.73 Million	-22,500 Reduced 2.72%	803,860 $130 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $496,577 - $569,541	-3,700 Reduced 0.45%	826,360 $111 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $1.68 Million - $2.08 Million	12,700 Added 1.55%	830,060 $135 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $676,809 - $856,359	-6,300 Reduced 0.76%	817,360 $111 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $340,480 - $386,496	3,200 Added 0.39%	823,660 $88.8 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $620,739 - $691,539	5,900 Added 0.72%	820,460 $92.4 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $5.01 Million - $5.52 Million	49,000 Added 6.4%	814,560 $88.2 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $1.49 Million - $2.01 Million	-18,500 Reduced 2.36%	765,560 $82 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $1.31 Million - $1.53 Million	15,200 Added 1.98%	784,060 $68.7 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $22.3 Million - $29.8 Million	303,498 Added 65.22%	768,860 $75.5 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $30 Million - $45.5 Million	465,362 New	465,362 $35.5 Million

Others Institutions Holding ABBV

# of Institutions

4,105

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $373B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.

Account

Homestead Advisers Corp Abb Vie Inc. Transaction History